In this study, we showed that continuous insulin infusion compared to bolus administration in patients with diabetes after CABG contributes to better postoperative glycemic control, in particular by reducing the range between the maximum and minimum glucose values and reducing the minimum glucose value during the day. The gene discussed is INS; the disease is diabetes mellitus.